- Home
- SKYH vs CCCC Comparison
SKYH vs CCCC Comparison
Compare SKYH & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYH
- CCCC
- Stock Information
- Founded
- SKYH 2017
- CCCC 2015
- Country
- SKYH United States
- CCCC United States
- Employees
- SKYH N/A
- CCCC N/A
- Industry
- SKYH Military/Government/Technical
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- SKYH Industrials
- CCCC Health Care
- Exchange
- SKYH Nasdaq
- CCCC Nasdaq
- Market Cap
- SKYH 336.5M
- CCCC 396.0M
- IPO Year
- SKYH N/A
- CCCC 2020
- Fundamental
- Price
- SKYH $13.01
- CCCC $3.95
- Analyst Decision
- SKYH Strong Buy
- CCCC Buy
- Analyst Count
- SKYH 2
- CCCC 6
- Target Price
- SKYH $15.50
- CCCC $10.67
- AVG Volume (30 Days)
- SKYH 115.7K
- CCCC 1.9M
- Earning Date
- SKYH 11-12-2024
- CCCC 10-31-2024
- Dividend Yield
- SKYH N/A
- CCCC N/A
- EPS Growth
- SKYH N/A
- CCCC N/A
- EPS
- SKYH N/A
- CCCC N/A
- Revenue
- SKYH $12,357,000.00
- CCCC $33,668,000.00
- Revenue This Year
- SKYH $88.91
- CCCC $75.79
- Revenue Next Year
- SKYH $109.92
- CCCC N/A
- P/E Ratio
- SKYH N/A
- CCCC N/A
- Revenue Growth
- SKYH 107.82
- CCCC 65.45
- 52 Week Low
- SKYH $8.26
- CCCC $3.61
- 52 Week High
- SKYH $14.52
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- SKYH 56.60
- CCCC 41.77
- Support Level
- SKYH $13.51
- CCCC $3.61
- Resistance Level
- SKYH $13.99
- CCCC $4.06
- Average True Range (ATR)
- SKYH 0.67
- CCCC 0.44
- MACD
- SKYH 0.00
- CCCC 0.01
- Stochastic Oscillator
- SKYH 56.09
- CCCC 22.82
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.